214 related articles for article (PubMed ID: 12920994)
21. [Epidemiological study of invasive nosocomial candidiasis in 2 teaching hospitals in Beijing].
Cao B; Wang H; Wu L; Sun WJ; Li F; Liu YM
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1970-3. PubMed ID: 19062737
[TBL] [Abstract][Full Text] [Related]
22. Distribution and epidemiology of Candida species causing fungemia at a Saudi Arabian hospital, 1996-2004.
Al-Tawfiq JA
Int J Infect Dis; 2007 May; 11(3):239-44. PubMed ID: 16859945
[TBL] [Abstract][Full Text] [Related]
23. Low rate of Candida parapsilosis-related colonization and infection in hospitalized preterm infants: a one-year prospective study.
Gagneur A; Sizun J; Vernotte E; de Parscau L; Quinio D; Le Flohic AM; Baron R
J Hosp Infect; 2001 Jul; 48(3):193-7. PubMed ID: 11439006
[TBL] [Abstract][Full Text] [Related]
24. Nosocomial candidaemia in a Finnish tertiary care centre during 1987-2004.
Poikonen E; Lyytikäinen O; Anttila VJ; Kuusela P; Koukila-Kähkölä P; Ollgren J; Ruutu P
Scand J Infect Dis; 2009; 41(8):590-6. PubMed ID: 19488931
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007.
Nace HL; Horn D; Neofytos D
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):289-94. PubMed ID: 19376670
[TBL] [Abstract][Full Text] [Related]
26. The predictors of outcome in immunocompetent patients with hematogenous candidiasis.
Safdar A; Bannister TW; Safdar Z
Int J Infect Dis; 2004 May; 8(3):180-6. PubMed ID: 15109594
[TBL] [Abstract][Full Text] [Related]
27. Outbreak of fungemia due to Candida parapsilosis in a pediatric oncology unit.
Barchiesi F; Caggiano G; Falconi Di Francesco L; Montagna MT; Barbuti S; Scalise G
Diagn Microbiol Infect Dis; 2004 Aug; 49(4):269-71. PubMed ID: 15313532
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
[TBL] [Abstract][Full Text] [Related]
29. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
[TBL] [Abstract][Full Text] [Related]
30. Nosocomial candidaemia in children: results of a 9-year study.
Celebi S; Hacimustafaoglu M; Ozdemir O; Ozkaya G
Mycoses; 2008 May; 51(3):248-57. PubMed ID: 18399906
[TBL] [Abstract][Full Text] [Related]
31. Yeasts species distribution in Neonatal Intensive Care Units in northeast Argentina.
Giusiano GE; Mangiaterra M; Rojas F; Gómez V
Mycoses; 2004 Aug; 47(7):300-3. PubMed ID: 15310334
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology of candidemia in a tertiary care centre of north India: 5-year study.
Xess I; Jain N; Hasan F; Mandal P; Banerjee U
Infection; 2007 Jun; 35(4):256-9. PubMed ID: 17646917
[TBL] [Abstract][Full Text] [Related]
33. [A multicenter study on fungemia caused by yeasts in Spain (April-June, 1997). A Work Group to Study Fungemia)].
Rodríguez-Tudela JL; Cuenca-Estrella M
Rev Clin Esp; 1999 Jun; 199(6):356-61. PubMed ID: 10432809
[TBL] [Abstract][Full Text] [Related]
34. Community-onset candidemia at a university hospital, 1995-2005.
Kung HC; Wang JL; Chang SC; Wang JT; Sun HY; Hsueh PR; Chen YC
J Microbiol Immunol Infect; 2007 Aug; 40(4):355-63. PubMed ID: 17712471
[TBL] [Abstract][Full Text] [Related]
35. Risk factors and outcome for nosocomial breakthrough candidaemia.
Pasqualotto AC; Nedel WL; Machado TS; Severo LC
J Infect; 2006 Mar; 52(3):216-22. PubMed ID: 15936825
[TBL] [Abstract][Full Text] [Related]
36. Candidaemia and antifungal susceptibility testing in a teaching hospital.
Tzar MN; Shamim AS
Med J Malaysia; 2009 Mar; 64(1):61-4. PubMed ID: 19852325
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality.
Weinberger M; Leibovici L; Perez S; Samra Z; Ostfeld I; Levi I; Bash E; Turner D; Goldschmied-Reouven A; Regev-Yochay G; Pitlik SD; Keller N
J Hosp Infect; 2005 Oct; 61(2):146-54. PubMed ID: 16009456
[TBL] [Abstract][Full Text] [Related]
39. Secular trends in nosocomial candidaemia in non-neutropenic patients in an Italian tertiary hospital.
Luzzati R; Allegranzi B; Antozzi L; Masala L; Pegoraro E; Azzini A; Concia E
Clin Microbiol Infect; 2005 Nov; 11(11):908-13. PubMed ID: 16216107
[TBL] [Abstract][Full Text] [Related]
40. Candida glabrata fungemia: experience in a tertiary care center.
Malani A; Hmoud J; Chiu L; Carver PL; Bielaczyc A; Kauffman CA
Clin Infect Dis; 2005 Oct; 41(7):975-81. PubMed ID: 16142662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]